These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. An extended-release formulation of oxybutynin chloride for the treatment of overactive urinary bladder. Goldenberg MM. Clin Ther; 1999 Apr; 21(4):634-42. PubMed ID: 10363730 [Abstract] [Full Text] [Related]
8. Efficacy of solifenacin in patients previously treated with tolterodine extended release 4 mg: results of a 12-week, multicenter, open-label, flexible-dose study. Chancellor MB, Zinner N, Whitmore K, Kobashi K, Snyder JA, Siami P, Karram M, Laramée C, Capo' JP, Seifeldin R, Forero-Schwanhaeuser S, Nandy I. Clin Ther; 2008 Oct; 30(10):1766-81. PubMed ID: 19014833 [Abstract] [Full Text] [Related]
9. Oxybutynin chloride topical gel: a new formulation of an established antimuscarinic therapy for overactive bladder. Staskin DR, Robinson D. Expert Opin Pharmacother; 2009 Dec; 10(18):3103-11. PubMed ID: 19954278 [Abstract] [Full Text] [Related]